Importantly, under HPK1 KD conditions, the dLN appear to be better orchestrated to generate a more robust anti-tumor immune reservoir as demonstrated by the augmented levels of CD4+Ki67+ and CD8+Ki67+ T cells. The gene discussed is CD4; the disease is neoplasm.